O'Shaughnessy Asset Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-2,433
Closed -$145K 2777
2021
Q3
$145K Sell
2,433
-826
-25% -$48.8K ﹤0.01% 1194
2021
Q2
$222K Sell
3,259
-1,288
-28% -$84K ﹤0.01% 980
2021
Q1
$315K Sell
4,547
-1,281
-22% -$98.6K 0.01% 758
2020
Q4
$448K Sell
5,828
-92
-2% -$6.9K 0.01% 542
2020
Q3
$443K Sell
5,920
-5,002
-46% -$333K 0.01% 474
2020
Q2
$688K Buy
10,922
+5,791
+113% +$319K 0.02% 340
2020
Q1
$216K Buy
5,131
+235
+5% +$10.8K 0.01% 451
2019
Q4
$222K Sell
4,896
-7,083
-59% -$335K ﹤0.01% 593
2019
Q3
$548K Buy
+11,979
New +$673K 0.01% 359

Other funds holding ARNA

O'Shaughnessy Asset Management's ARNA Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2021, closing a stake of 2,433 shares — an estimated $145K sold.

O'Shaughnessy Asset Management first reported a position in ARNA in Q3 2019 and held it in 9 quarters. The position peaked at $688K in Q2 2020. 316 funds tracked by Wall St. Rank hold ARNA as of Q4 2021.

  • O'Shaughnessy Asset Management reported no remaining Arena Pharmaceuticals Inc position as of Q4 2021 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 2,433 Arena Pharmaceuticals Inc shares in Q4 2021, an estimated $145K.
  • O'Shaughnessy Asset Management first reported a position in Arena Pharmaceuticals Inc in Q3 2019 and held it in 9 quarters.
  • O'Shaughnessy Asset Management's Arena Pharmaceuticals Inc position peaked at $688K in Q2 2020.
  • 316 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.